LCP
HAE icon

Lombardia Capital Partners’s Haemonetics HAE Stock Holding History

Lombardia Capital Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,928
Closed -$242K – 223
2014
Q3 		$242K Buy
+6,928
New +$247K 0.01% 207
2014
Q2 		– Sell
-14,169
Closed -$462K – 220
2014
Q1 		$462K Sell
14,169
-5,868
-29% -$224K 0.01% 198
2013
Q4 		$844K Buy
+20,037
New +$825K 0.02% 184

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Lombardia Capital Partners's HAE Position: Q4 2014 in Review

Lombardia Capital Partners sold out of Haemonetics (HAE) in Q4 2014, closing a stake of 6,928 shares — an estimated $242K sold.

Lombardia Capital Partners first reported a position in HAE in Q4 2013 and held it in 3 quarters. The position peaked at $844K in Q4 2013. 172 funds tracked by Wall St. Rank hold HAE as of Q4 2014.

  • Lombardia Capital Partners reported no remaining Haemonetics position as of Q4 2014 after selling out during the quarter.
  • Lombardia Capital Partners sold 6,928 Haemonetics shares in Q4 2014, an estimated $242K.
  • Lombardia Capital Partners first reported a position in Haemonetics in Q4 2013 and held it in 3 quarters.
  • Lombardia Capital Partners's Haemonetics position peaked at $844K in Q4 2013.
  • 172 funds tracked by Wall St. Rank held Haemonetics as of Q4 2014.

Based on Lombardia Capital Partners's 13F filing for Q4 2014, filed 21 Jan 2015.